Balyasny Asset Management’s Aceragen Inc ACGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-626
Closed -$112K 2136
2018
Q2
$112K Buy
626
+288
+85% +$67.2K ﹤0.01% 1702
2018
Q1
$84K Sell
338
-99
-23% -$27.2K ﹤0.01% 1840
2017
Q4
$125K Buy
437
+305
+231% +$87.1K ﹤0.01% 1965
2017
Q3
$40K Buy
+132
New +$34.5K ﹤0.01% 1823
2015
Q4
Sell
-318
Closed -$145K 1506
2015
Q3
$145K Sell
318
-97
-23% -$42.9K ﹤0.01% 1045
2015
Q2
$209K Buy
+415
New +$190K ﹤0.01% 1013

Other funds holding ACGN

Balyasny Asset Management's ACGN Position: Q3 2018 in Review

Balyasny Asset Management sold out of Aceragen Inc (ACGN) in Q3 2018, closing a stake of 626 shares — an estimated $112K sold.

Balyasny Asset Management first reported a position in ACGN in Q2 2015 and held it in 6 quarters. The position peaked at $209K in Q2 2015. 72 funds tracked by Wall St. Rank hold ACGN as of Q3 2018.

  • Balyasny Asset Management reported no remaining Aceragen Inc position as of Q3 2018 after selling out during the quarter.
  • Balyasny Asset Management sold 626 Aceragen Inc shares in Q3 2018, an estimated $112K.
  • Balyasny Asset Management first reported a position in Aceragen Inc in Q2 2015 and held it in 6 quarters.
  • Balyasny Asset Management's Aceragen Inc position peaked at $209K in Q2 2015.
  • 72 funds tracked by Wall St. Rank held Aceragen Inc as of Q3 2018.

Based on Balyasny Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.